Financial News
Creative Biolabs Serves as an Activist in Immunotherapy Development
New York, USA - March 27, 2023 - Immunotherapy is another sword found to defeat cancer after targeted therapy. Creative Biolabs, being a pioneer in providing services for immunotherapeutic development, depends on its knowledgeable scientists and state-of-the-art technologies to deliver high-quality services to researchers worldwide who are committed to innovating immunotherapy.
Creative Biolabs offers technical services for several types of immunotherapies as follows:
Immune Checkpoint Therapy
"Immune checkpoint blockade therapy is based on inhibiting the binding of programmed death receptors expressed on the surface of T cells to their ligands. Immune checkpoint receptors significantly maintain the immunologic balance and regulate tumorigenesis," a scientist at Creative Biolabs emphasized.
Creative Biolabs, deeply researching the signaling pathways and significance of immune checkpoint molecules, establishes a platform related to immune checkpoints, and provides a variety of immune checkpoint-based drug development services:
* Immune Checkpoint Antibody Development
* Immune Checkpoint Protein Development
* Immune Checkpoint Targeted Peptide Development
* Immune Checkpoint Targeted Small Molecular Development
γδ T Cell Therapy
The extraordinary properties of γδ T cells prepare them with great potential for immunotherapy of oncology, infections, and autoimmune diseases. Creative Biolabs offers research-assisted γδ T Cell services, including but not limited to:
* γδ T cell isolation, activation, expansion, characterization, and migration assay.
* A series of technical supports to predict and analyze the function of γδ T-cell receptors specifically involve γδ TCR repertoire and transcriptome analysis, γδ TCR generation, γδ TCR-ligand reaction analysis, etc.
Macrophage-Based Therapy
The scientist added, "Similar to T cells, macrophages as immune cells with strong phagocytic functions also have the potential to kill tumor cells. Macrophage-based therapy is gaining momentum as a promising strategy for cancer immunotherapy."
Creative Biolabs furnishes forefront macrophage reprogramming services to greatly inhibit cancer development. Additionally, targets such as macrophage receptors (i.e., toll-like receptors), RNA delivery, and antibodies have also been considered to achieve the same immune effect.
Other macrophage-related services supplied by Creative Biolabs contain macrophage characterization, engineering services for drug delivery, marker development, and so on.
Mentioned above is a partial list of immunotherapeutic development services. Further services can be found at https://www.creative-biolabs.com.
About Creative Biolabs
Creative Biolabs, equipped with a team of experienced scientists and purpose-built facilities, is well-established in immunotherapies with varied assistants in meeting the diversified needs of global clients and ensuring reliable support at any stage of our clients' research process.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.